BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26787772)

  • 1. Targeting Epigenetic Mechanisms for Chronic Pain: A Valid Approach for the Development of Novel Therapeutics.
    Ligon CO; Moloney RD; Greenwood-Van Meerveld B
    J Pharmacol Exp Ther; 2016 Apr; 357(1):84-93. PubMed ID: 26787772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could targeting epigenetic processes relieve chronic pain states?
    Géranton SM; Tochiki KK
    Curr Opin Support Palliat Care; 2015 Jun; 9(2):138-46. PubMed ID: 25923342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting epigenetic mechanisms for chronic visceral pain: A valid approach for the development of novel therapeutics.
    Louwies T; Ligon CO; Johnson AC; Greenwood-Van Meerveld B
    Neurogastroenterol Motil; 2019 Mar; 31(3):e13500. PubMed ID: 30393913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation of chronic pain.
    Liang L; Lutz BM; Bekker A; Tao YX
    Epigenomics; 2015; 7(2):235-45. PubMed ID: 25942533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacotherapy of chronic neuropathic pain].
    Otto J; Forstenpointner J; Binder A; Baron R
    Internist (Berl); 2019 Jul; 60(7):711-723. PubMed ID: 31187164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of persistent pain.
    Bai G; Ren K; Dubner R
    Transl Res; 2015 Jan; 165(1):177-99. PubMed ID: 24948399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm.
    Taneja A; Della Pasqua O; Danhof M
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1219-1236. PubMed ID: 28894907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting epigenetic mechanisms for pain relief.
    Géranton SM
    Curr Opin Pharmacol; 2012 Feb; 12(1):35-41. PubMed ID: 22056026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics of chronic pain after thoracic surgery.
    Mauck M; Van de Ven T; Shaw AD
    Curr Opin Anaesthesiol; 2014 Feb; 27(1):1-5. PubMed ID: 24300461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment of pain: future trends and novel insights.
    Cascorbi I
    Clin Pharmacol Ther; 2015 Feb; 97(2):104-8. PubMed ID: 25670508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic mechanisms of chronic pain.
    Descalzi G; Ikegami D; Ushijima T; Nestler EJ; Zachariou V; Narita M
    Trends Neurosci; 2015 Apr; 38(4):237-46. PubMed ID: 25765319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of chronic neuropathic pain with single and compounded topical analgesics.
    Knezevic NN; Tverdohleb T; Nikibin F; Knezevic I; Candido KD
    Pain Manag; 2017 Nov; 7(6):537-558. PubMed ID: 29125423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve Injury-Induced Chronic Pain Is Associated with Persistent DNA Methylation Reprogramming in Dorsal Root Ganglion.
    Garriga J; Laumet G; Chen SR; Zhang Y; Madzo J; Issa JJ; Pan HL; Jelinek J
    J Neurosci; 2018 Jul; 38(27):6090-6101. PubMed ID: 29875269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetics and the transition from acute to chronic pain.
    Buchheit T; Van de Ven T; Shaw A
    Pain Med; 2012 Nov; 13(11):1474-90. PubMed ID: 22978429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and molecular mechanisms driving neuropathic pain: recent advancements and challenges.
    Fernandes V; Sharma D; Vaidya S; P A S; Guan Y; Kalia K; Tiwari V
    Expert Opin Ther Targets; 2018 Feb; 22(2):131-142. PubMed ID: 29285962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitor-induced emergence of synaptic δ-opioid receptors and behavioral antinociception in persistent neuropathic pain.
    Tao W; Zhou W; Wang Y; Sun T; Wang H; Zhang Z; Jin Y
    Neuroscience; 2016 Dec; 339():54-63. PubMed ID: 27646288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain.
    Notartomaso S; Mascio G; Bernabucci M; Zappulla C; Scarselli P; Cannella M; Imbriglio T; Gradini R; Battaglia G; Bruno V; Nicoletti F
    Mol Pain; 2017 Jan; 13():1744806917697009. PubMed ID: 28326943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugging the pain epigenome.
    Niederberger E; Resch E; Parnham MJ; Geisslinger G
    Nat Rev Neurol; 2017 Jul; 13(7):434-447. PubMed ID: 28548108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathic and non-neuropathic chronic pain at GP encounters: Prevalence, patient characteristics, suffering and pregabalin use.
    Henderson J; Pollack AJ; Pan Y; Miller GC
    Aust Fam Physician; 2016 Nov; 45(11):783-786. PubMed ID: 27806445
    [No Abstract]   [Full Text] [Related]  

  • 20. A Practical Approach to Using Adjuvant Analgesics in Older Adults.
    Portenoy RK
    J Am Geriatr Soc; 2020 Apr; 68(4):691-698. PubMed ID: 32216151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.